{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:49:15Z","timestamp":1761648555818,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ad.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T09:15:01Z","timestamp":1523265301000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Disecci\u00f3n ganglionar en el paciente con melanoma y met\u00e1stasis en el ganglio centinela: propuesta de decisi\u00f3n basada en la evidencia actual"],"prefix":"10.1016","volume":"109","author":[{"given":"D.","family":"Moreno-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Boada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferr\u00e1ndiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nagore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Botella-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.ad.2018.02.008_bib0195","first-page":"1","article-title":"Malignant melanoma S3-guideline \u201cDiagnosis, therapy and follow-up of melanoma\u201d","volume":"11","author":"Pflugfelder","year":"2013","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.ad.2018.02.008_bib0200","unstructured":"National Comprehensive Cancer Network clinical practice guidelines in oncology. Melanoma version 1. 2017. November 2016. Disponible en: https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/melanoma.pdf"},{"key":"10.1016\/j.ad.2018.02.008_bib0205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg."},{"key":"10.1016\/j.ad.2018.02.008_bib0210","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.02.008_bib0215","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1200\/JCO.2009.26.8292","article-title":"The breast cancer alternative hypothesis: Is there evidence to justify replacing it?","volume":"28","author":"Fisher","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0220","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0001-7310(07)70128-X","article-title":"Estudio temporal de los diferentes patrones metast\u00e1sicos en la progresi\u00f3n del melanoma cut\u00e1neo","volume":"98","author":"Tejera-Vaquerizo","year":"2007","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2018.02.008_bib0225","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.jid.2017.07.006","article-title":"Serial or parallel metastasis of cutaneous melanoma? A study of the German Central Malignant Melanoma Registry","volume":"137","author":"Gassenmaier","year":"2017","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2018.02.008_bib0230","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ad.2018.02.008_bib0235","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): A multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0245","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.02.008_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","article-title":"The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients","volume":"50","author":"Van der Ploeg","year":"2014","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0255","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","article-title":"Observation after a positive sentinel lymph node biopsy in patients with melanoma","volume":"21","author":"Bamboat","year":"2014","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1245\/s10434-009-0836-3","article-title":"Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy","volume":"17","author":"Kingham","year":"2010","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jamcollsurg.2016.01.045","article-title":"Impact of completion lymph node dissection on patients with positive sentinel lymph node biopsy in melanoma","volume":"223","author":"Lee","year":"2016","journal-title":"J Am Coll Surg."},{"key":"10.1016\/j.ad.2018.02.008_bib0270","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/CMR.0000000000000081","article-title":"Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?","volume":"24","author":"Satzger","year":"2014","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ad.2018.02.008_bib0275","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/bjs.8878","article-title":"Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection","volume":"99","author":"Van der Ploeg","year":"2012","journal-title":"Br J Surg."},{"key":"10.1016\/j.ad.2018.02.008_bib0280","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1245\/ASO.2006.03.058","article-title":"Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: A multi-institutional study","volume":"13","author":"Wong","year":"2006","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0285","unstructured":"National Comprehensive Cancer Network clinical practice guidelines in oncology. Melanoma version 1.2018."},{"key":"10.1016\/j.ad.2018.02.008_bib0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2014 Update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice guideline update","volume":"25","author":"Wong","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2017.06.006","article-title":"Adjuvant interferon-\u03b1 for the treatment of high-risk melanoma: An individual patient data meta-analysis","volume":"82","author":"Ives","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0305-7372(03)00074-4","article-title":"Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials","volume":"29","author":"Wheatley","year":"2003","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ad.2018.02.008_bib0310","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008955.pub2","article-title":"Interferon alpha for the adjuvant treatment of cutaneous melanoma","author":"Mocellin","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ad.2018.02.008_bib0315","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejca.2011.09.028","article-title":"Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991","volume":"48","author":"Eggermont","year":"2012","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0320","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0325","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in Stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.02.008_bib0330","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.02.008_bib0335","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejca.2017.09.014","article-title":"The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients","volume":"86","author":"Eggermont","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0340","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.09.002","article-title":"Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria","volume":"87","author":"Madu","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0345","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/1097-0142(20000601)88:11<2534::AID-CNCR15>3.0.CO;2-2","article-title":"Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: Results of a prospective study of 1288 patients","volume":"88","author":"Blum","year":"2000","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0350","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/1097-0142(20010615)91:12<2409::AID-CNCR1275>3.0.CO;2-S","article-title":"Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients","volume":"91","author":"Voit","year":"2001","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.02.008_bib0355","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2009.25.7428","article-title":"Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma","volume":"28","author":"Voit","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2018.02.008_bib0360","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJMra0909487","article-title":"Point-of-care ultrasonography","volume":"364","author":"Moore","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.02.008_bib0365","unstructured":"Oxford Centre for Evidence-based Medicine \u2014 Levels of Evidence; March 2009 [consultado 26 Dic 2017]. Disponible en: http:\/\/www.cebm.net\/blog\/2009\/06\/11\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/"},{"key":"10.1016\/j.ad.2018.02.008_bib0370","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/SLA.0b013e31818fefe0","article-title":"Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: A multicenter study in 388 patients with positive sentinel nodes","volume":"248","author":"Van Akkooi","year":"2008","journal-title":"Ann Surg."},{"key":"10.1016\/j.ad.2018.02.008_bib0375","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/RLU.0000000000000996","article-title":"18F-FDG-PET\/CT in the staging and management of melanoma: A prospective multicenter Ontario PET registry study","volume":"41","author":"Singnurkar","year":"2016","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.ad.2018.02.008_bib0380","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1056\/NEJMe1704290","article-title":"The enigma of regional lymph nodes in melanoma","volume":"376","author":"Coit","year":"2017","journal-title":"N Engl J Med."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731018300838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731018300838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:07:22Z","timestamp":1757552842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731018300838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0001731018300838"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2018.02.008","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disecci\u00f3n ganglionar en el paciente con melanoma y met\u00e1stasis en el ganglio centinela: propuesta de decisi\u00f3n basada en la evidencia actual","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}